130838-36-7 Usage
Uses
Used in Pharmaceutical Industry:
2,6-DICHLORO-PYRIMIDINE-4,5-DIAMINE is used as a key intermediate in the synthesis of antineoplastic drugs for the treatment of cancer. Its chemical structure allows for the development of compounds that can target and inhibit the growth of cancer cells, making it a valuable component in oncology research and drug development.
2,6-DICHLORO-PYRIMIDINE-4,5-DIAMINE is also used as an intermediate in the production of antiviral drugs, which are essential in combating viral infections and diseases. Its role in the synthesis of these drugs contributes to the development of effective treatments and prevention strategies against various viral threats.
Used in Agrochemical Industry:
In the agrochemical sector, 2,6-DICHLORO-PYRIMIDINE-4,5-DIAMINE is utilized as an intermediate in the manufacturing of herbicides and pesticides. Its incorporation into these products aids in the control of weeds and pests, thereby enhancing crop protection and contributing to increased agricultural productivity.
Safety Measures:
Due to the potential toxicity of 2,6-DICHLORO-PYRIMIDINE-4,5-DIAMINE, it is crucial to handle and use 2,6-DICHLORO-PYRIMIDINE-4,5-DIAMINE with appropriate safety measures. This includes wearing personal protective equipment, working in well-ventilated areas, and following proper disposal and storage protocols to minimize exposure and environmental impact.
Check Digit Verification of cas no
The CAS Registry Mumber 130838-36-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,0,8,3 and 8 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 130838-36:
(8*1)+(7*3)+(6*0)+(5*8)+(4*3)+(3*8)+(2*3)+(1*6)=117
117 % 10 = 7
So 130838-36-7 is a valid CAS Registry Number.
130838-36-7Relevant academic research and scientific papers
CD73 INHIBITORS
-
Paragraph 00412, (2019/05/22)
Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of cancer, infections, and neurodegenerative diseases.
CD73 INHIBITORS
-
Paragraph 00416, (2018/12/03)
Described herein are CD73 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of cancer, infections, and neurodegenerative diseases.
